3. Beal JE, et al. 1995; Beal JE, Olson R, Lefkowitz L, Laubenstein L, Bellman P, Yangco B, Morales JO, Murphy R, Powderly W, Plasse TF, Mosdell KW, Shepard KV. 1997. “Long-term efficiency and safety of dronabinol for acquired immunodeficiency syndrome-associated anorexia. ” Journal of Pain Management 14:7-14.

4. Struwe M, Kaempfer SH, Geiger CJ, Pavia AT, Plasse TF, Shepard KV, Ries K, Evans TG. 1993. “Effect of dronabinol on nutritional status in HIV infection.” Annals of Pharmacotherapy 27:827-831.

5. Foltin RW, Fischman MW, Byrne MF. 1988. “Effects of smoked marijuana on food intake and body weight of humans living in a residential laboratory.” Appetite 11:1-14; Mattes RD, Engelman K, Shaw LM, ElSohly MA. 1994. “Cannabinoids and appetite stimulation.” Pharmacology, Biochemistry and Behavior 49:187-195.

6. Calhoun SR, Galloway GP, Smith DE. 1998. “Abuse potential of dronabinol (Marinol).” Journal of Psychoactive Drugs 30:187-196.

The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement